Clinical Trial Opportunity for Triple-Negative Breast Cancer
| Date | Form | Description | XBRL | Pages |
|---|---|---|---|---|
| 05/04/23 | 8-K | Form 8-K: Current report filing |
|
5 |
| 05/04/23 | 10-Q | Form 10-Q: Quarterly report pursuant to Section 13 or 15(d) |
|
32 |
| 04/28/23 | DEFA14A | Form DEFA14A: Additional definitive proxy soliciting materials and Rule 14(a)(12) material | 3 | |
| 04/28/23 | DEF 14A | Form DEF 14A: Definitive proxy statements | 29 | |
| 03/16/23 | 4 | Form 4: Statement of changes in beneficial ownership of securities | 1 | |
| 03/16/23 | 3 | Form 3: Initial statement of beneficial ownership of securities | 2 | |
| 03/16/23 | 10-K/A | Form 10-K/A: Annual report pursuant to Section 13 and 15(d) |
|
5 |
| 03/09/23 | 8-K | Form 8-K: Current report filing |
|
5 |
| 03/09/23 | 10-K | Form 10-K: Annual report pursuant to Section 13 and 15(d) |
|
104 |
| 02/14/23 | SC 13G/A | Form SC 13G/A: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions | 7 |